Abbott Laboratories CEO Robert Ford unpacked his company’s latest quarterly report in a Thursday interview with CNBC’s Jim ...

Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...

The healthcare-products maker trimmed and narrowed its guidance for the year while reporting strong profit and sales gains in ...

"Halfway through the year, we delivered high single-digit organic sales growth, double-digit EPS growth, significantly ...

Shares of Abbott Laboratories (NYSE:ABT) lost ~5% in the premarket on Thursday after the MedTech company provided its ...

Investing.com -- Jefferies upgraded Abbott Laboratories (NYSE: ABT) to Buy from Hold, calling the market reaction to the ...

Abbott Laboratories’ Debt totaled $15 Bil at the end of the latest quarter, while its market capitalization stands at $233 ...

Discover Abbott Laboratories' Q2 2025 highlights: resilience drives high single-digit growth, double-digit EPS, and pipeline innovations.

On the same day that United Airlines forecast stability, Abbott Labs warned investors to expect a $200 million hit.

Abbott Laboratories closed 12.43% short of its 52-week high of $141.23, which the company reached on March 4th.

Abbott Laboratories closed 6.52% below its 52-week high of $141.23, which the company reached on March 4th.

President Trump’s made-for-TV unboxing of Abbott Laboratories’ toaster-sized testing instrument beamed into millions of households last month as he displayed the unit in the Rose Garden.